| Display title | Company:Medicago Inc. |
| Default sort key | Medicago Inc. |
| Page length (in bytes) | 18,176 |
| Namespace ID | 3042 |
| Namespace | Company |
| Page ID | 540357 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>TextAI2 |
| Date of page creation | 20:15, 9 February 2024 |
| Latest editor | imported>TextAI2 |
| Date of latest edit | 20:15, 9 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Medicago Inc. was a Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as bioreactors to produce proteins, candidate vaccines, and medications. By using live plant leaves as hosts in the discovery and manufacturing process... |
